Plerixafor Injection — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Plerixafor Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Mar 13, 2026.

Shortage details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
65219-284-12
Dosage Form
Injection
Presentation
Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)
Initial Posting
Mar 13, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.